Anthraquinone/coumarin dimer novel skeleton compound, and preparation method and application thereof

The technology of a skeleton compound, coumarin, is applied in the fields of organic chemistry, drug combination, metabolic diseases, etc., and can solve problems such as unseen structures, preparation methods and application reports.

Active Publication Date: 2021-07-06
BINZHOU MEDICAL COLLEGE +1
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are many anthraquinone dimers and coumarin dimers reported in the literature, mainly anthraquinone-anthraquinone, anthraquinone-koushanone, coumarin-coumarin and coumarin-chalcone dimer and other types, the connection mode has phenyl-phenyl coupling between the mother nuclei, and also has an oxygen atom between the mother nuclei. The structure of the compound formed by anthraquinone-coumarin in the present invention through methylene coupling, Preparation method and application report

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anthraquinone/coumarin dimer novel skeleton compound, and preparation method and application thereof
  • Anthraquinone/coumarin dimer novel skeleton compound, and preparation method and application thereof
  • Anthraquinone/coumarin dimer novel skeleton compound, and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] The preparation of embodiment 1 ruby ​​euphorquinone A

[0026] Red Euphorbia 20Kg, pulverized and ultrasonically extracted with 95% ethanol at room temperature, the extracts were combined and evaporated to dryness under reduced pressure to obtain 3.9Kg of extract. After the extract was dissolved in water, it was extracted three times with ethyl acetate, and the solvent was evaporated to obtain 400 g of ethyl acetate extract. The ethyl acetate fraction was separated by silica gel column chromatography, and eluted with petroleum ether / acetone at volume ratios of 10:0, 10:1, 10:2, 2:1, 1:1, and 0:1 in sequence. Petroleum ether / acetone 2:1 eluted fraction (30g) was separated by silica gel column chromatography again, and washed with chloroform / methanol with a volume ratio of 100:1, 10:1, 2:1, 1:1, and 0:1 in sequence take off. Chloroform / methanol 1:1 eluted fraction (4.7g) was separated by MCI column chromatography, and eluted with 30%, 50%, 70%, 90%, and 100% methanol / w...

Embodiment 2

[0028] Example 2 PTP1B and TCPTP inhibitory activity evaluation

[0029] Compounds were prepared in gradient concentration with DMSO (final concentrations were 50, 25, 12.5, 6.2, 3.1, 1.6 μM, respectively). Add the pre-prepared enzyme solution (buffer containing 25mM Hepes pH 7.5, 150mM NaCl, 5mM DTT, 2mM EDTA, containing 0.1μg PTP1B or 0.15μg TCPTP) into the 96-well plate, 90μL per well, add 1μL of the compound solution, Using DMSO as a blank control, three parallel wells were set up for each concentration, and the 96-well plate was placed in a constant temperature shaker and shaken at 37°C for 15 minutes. After 15 minutes, 10 μL of p-NPP solution with a final concentration of 4 mM was added, and shaken in a constant temperature shaker at 37° C. for 30 minutes. Take it out after 30 minutes, add 20 μL 3M NaOH solution in turn to terminate the reaction, and finally measure the OD value at 405 nm in a microplate reader, and calculate the inhibitory rate and IC of the compound o...

Embodiment 3

[0035] Example 3 PTP1B enzyme inhibition kinetics experiment

[0036] Add the pre-prepared PTP1B solution into a 96-well plate, 90 μL per well, add 1 μL of the compound solution to be tested, and the final concentrations are 0, 1, 2.5, 5, and 10 μM, respectively, and set up three replicate wells for each concentration. As a blank control, the 96-well plate was placed in a constant temperature shaker and shaken at 37°C for 15 minutes. Then add p-NPP solution (final concentrations are 2, 4, and 8 mM respectively), and immediately use a microplate reader to measure the change of OD value at 405 nm within 15 min, and calculate the initial rate of enzymolysis. The concentration of the compound and the initial rate of enzymolysis were plotted by Dixon plot, and the slope of the straight line at each concentration obtained by Lineweaver-Burk plot was plotted by the concentration of the compound and the slope to obtain the value of the inhibition constant Ki. The type of inhibition o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an anthraquinone / coumarin dimer novel skeleton compound, and a preparation method and application thereof. The structural formula of the dimer compound is shown in the specification. Anthraquinone and coumarin are coupled through a methylene carbon bridge to form the compound with a novel skeleton. The compound can efficiently and highly selectively inhibit the activity of protein tyrosine phosphatase 1B. The invention relates to the compound, the preparation method thereof and application of the compound in preparation of PTP1B inhibitors, medicines for treating type 2 diabetes mellitus and antitumor medicines.

Description

technical field [0001] The invention belongs to the field of pharmaceutical compounds, and in particular relates to a new skeleton compound derived from Euphorbia anthraquinone and coumarin coupled with carbon-carbon bonds, a preparation method of the compound, and the use of the compound in the preparation of PTP1B enzyme inhibitors , Type 2 diabetes treatment drug and / or application in antitumor drug. Background technique [0002] Protein kinases and phosphatases are respectively responsible for the phosphorylation and dephosphorylation of proteins after translation, and cooperate to regulate cell signaling pathways to maintain normal life activities. When this balance is broken, it will trigger various diseases such as cancer, immune, and metabolic systems. Diseases, so both are important targets for drug development. Protein tyrosine phosphatase 1B (PTP1B) is a subtype of the PTP family distributed in cells. It was first isolated from human placenta tissue and widely di...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D311/16A61P3/10A61P35/00
CPCC07D311/16A61P3/10A61P35/00
Inventor 赵峰马丽王春华侯桂革曲兆霞
Owner BINZHOU MEDICAL COLLEGE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap